Results From Two Phase II Trials Add To Understanding Of Ticagrelor (BRILINTA(TM)) And How It Works In The Body

Links shared publicly online about this topic.

  • 1,591
    total visits

Results From Two Phase II Trials Add To Understanding Of Ticagrelor (BRILINTA(TM)) And How It Works In The Body

medicalnewstoday.com —

Astrazeneca (nyse: azn) announced the results of the phase ii studies, onset/offset and respond for ticagrelor (brilinta(tm)) at the annual american heart association (aha) scientific sessions in

View full resource at medicalnewstoday.com

Tags: Heart, American Heart Association, Anti-Clotting Medication, Brilinta, AstraZeneca

  • Share

Most Recently Shared on November 19, 2009 at 3:13 pm By:

mnt_clinical MNT Clinical Trials

Results From Two Phase II Trials Add To Understanding Of Ticagrelor (BRILINTA(TM)) And How It Works In The Body.. http://bit.ly/2XfQQM

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Cardiovascular MNT Cardiovascular

Advertisement